Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F8ZLH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,284
Award facts
- Contract value 100% obligated
- $11,283.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,283.55 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for RINVOQ ER, a Pfizer-manufactured JAK inhibitor, exemplifies the company's role in furnishing specialty medications across multiple therapeutic domains through the DLA's pharmaceutical supply chain. The underlying IDC vehicle enables flexible procurement of pharmaceuticals and medical commodities to support Defense Health Agency operations and other federal healthcare systems worldwide, with DLA planning to establish subsequent Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DR26F8ZLH?
SPE2DR26F8ZLH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F8ZLH worth?
The government has obligated $11,284 on SPE2DR26F8ZLH.
Is contract SPE2DR26F8ZLH an order under another contract?
Yes. SPE2DR26F8ZLH is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZLH competed?
The extent of competition for SPE2DR26F8ZLH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award